BETHLEHEM, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today a new collaboration between Diversigen, Inc., a subsidiary of OraSure Technologies, and Mars Petcare, which will help researchers better understand pet health. As part of the MARS PETCARE BIOBANK™ project, Diversigen will sequence microbiome samples from cats and dogs of all breeds and breed makeups in efforts to improve pet care.
GOP Senator Who Owns Meta Stock Denies Conflict of Interest Ahead Of TikTok Ban Vote: ‘I Am Not Fighting Against A Company’
While Mullin denied divulging details about his market activities, he mentioned that he was not fighting against a company, but the Chinese Communist Party.
